Rose Research Center

NCT06554873

Phase 3, Completed, 2024, 150 people, 15 Aug 2024, clinicaltrials.gov

NCT06088862

Phase 3, Terminated, 2023, 4 people, 18 Oct 2023, clinicaltrials.gov

NCT05205811

Phase 3, Completed, 2021, 180 people, 25 Jan 2022, clinicaltrials.gov

NCT04388319

Phase 3, Completed, 2020, 26 people, 14 May 2020, clinicaltrials.gov

NCT04210180

Phase 2/3, Completed, 2019, 25 people, 24 Dec 2019, clinicaltrials.gov

NCT04188106

Phase 4, Completed, 2019, 26 people, 5 Dec 2019, clinicaltrials.gov

International consensus recommendations for smoking cessation in type 2 diabetes from the DiaSmokeFree Working group

Employment, 28 Aug 2026, pubmed.ncbi.nlm.nih.gov